These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 9198226)

  • 21. The role of platelets in the pathogenesis of thrombosis and hemorrhage in patients with thrombocytosis.
    Walsh PN; Murphy S; Barry WE
    Thromb Haemost; 1977 Dec; 38(4):1085-96. PubMed ID: 579686
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Thrombohaemorrhagic complications in 101 cases of myeloproliferative disorders: relationship to platelet number and function.
    Barbui T; Cortelazzo S; Viero P; Bassan R; Dini E; Semeraro N
    Eur J Cancer Clin Oncol; 1983 Nov; 19(11):1593-9. PubMed ID: 6580171
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Platelets in myeloproliferative disorders. I. A comparative evaluation with certain platelet function tests.
    Boneu B; Nouvel C; Sie P; Caranobe C; Combes D; Laurent G; Pris J; Bierme R
    Scand J Haematol; 1980 Sep; 25(3):214-20. PubMed ID: 7466310
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Deficiency of platelet lipoxygenase activity in myeloproliferative disorders.
    Schafer AI
    N Engl J Med; 1982 Feb; 306(7):381-6. PubMed ID: 6799826
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Platelet anomaly in an eosinophilic myelophroliferative syndrome].
    Wautier JL; Dupuy E; Michel H; Caen JP
    Nouv Presse Med; 1976 Mar; 5(11):704-6. PubMed ID: 1083506
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Acquired von Willebrand disease due to increasing platelet count can readily explain the paradox of thrombosis and bleeding in thrombocythemia.
    Michiels JJ
    Clin Appl Thromb Hemost; 1999 Jul; 5(3):147-51. PubMed ID: 10725999
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [What vascular events suggest a myeloproliferative disorder?].
    Hachulla E; Rose C; Trillot N; Caulier-Leleu MT; Pasturel-Michon U
    J Mal Vasc; 2000 Dec; 25(5):382-387. PubMed ID: 11148402
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Bleeding and thrombosis in the myeloproliferative disorders.
    Schafer AI
    Blood; 1984 Jul; 64(1):1-12. PubMed ID: 6375757
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Myeloproliferative disorders--neurological complications.
    Tarach JS; Nowicka-Tarach BM
    Med Sci Monit; 2000; 6(2):421-5. PubMed ID: 11208349
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Analysis of risk factors predicting thrombotic and/or haemorrhagic complications in 306 patients with essential thrombocythemia.
    Radaelli F; Colombi M; Calori R; Zilioli VR; Bramanti S; Iurlo A; Zanella A
    Hematol Oncol; 2007 Sep; 25(3):115-20. PubMed ID: 17464935
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Thromboxane-dependent platelet activation in vivo precedes arterial thrombosis in thrombocythaemia: a rationale for the use of low-dose aspirin as an antithrombotic agent.
    van Genderen PJ; Prins FJ; Michiels JJ; Schrör K
    Br J Haematol; 1999 Mar; 104(3):438-41. PubMed ID: 10086775
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Thrombotic risk in myeloproliferative neoplasms: what the general practitioner needs to know].
    Casini A; Boehlen F; Lecompte T; de Moerloose P
    Rev Med Suisse; 2013 Feb; 9(372):315-8, 320. PubMed ID: 23469399
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Erythromelalgia--a thrombotic complication in chronic myeloproliferative disorders.
    Tarach JS; Nowicka-Tarach BM; Matuszek B; Nowakowski A
    Med Sci Monit; 2000; 6(1):204-8. PubMed ID: 11208311
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Erythromelalgic, thrombotic and haemorrhagic manifestations of thrombocythaemia.
    van Genderen PJ; Michiels JJ
    Presse Med; 1994 Jan; 23(2):73-7. PubMed ID: 8140075
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Bleeding and thrombosis in multiple myeloma and related plasma cell disorders.
    Coppola A; Tufano A; Di Capua M; Franchini M
    Semin Thromb Hemost; 2011 Nov; 37(8):929-45. PubMed ID: 22198858
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of microgravity and hypergravity on platelet functions.
    Dai K; Wang Y; Yan R; Shi Q; Wang Z; Yuan Y; Cheng H; Li S; Fan Y; Zhuang F
    Thromb Haemost; 2009 May; 101(5):902-10. PubMed ID: 19404544
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Pathogenesis of thrombotic and hemorrhagic complications in myeloproliferative and myelodysplastic syndromes].
    Vlădăreanu AM; Popov V; Bumbea H; Ciufu C; Vasilache V; Petre A; Onisâi M
    Rev Med Chir Soc Med Nat Iasi; 2011; 115(1):14-9. PubMed ID: 21688554
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Thrombocytosis: too much of a good thing?
    Schafer AI
    Trans Am Clin Climatol Assoc; 2002; 113():68-76; discussion 76-7. PubMed ID: 12053719
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The use of aspirin in polycythaemia vera and primary thrombocythaemia.
    Willoughby S; Pearson TC
    Blood Rev; 1998 Mar; 12(1):12-22. PubMed ID: 9597194
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Abnormalities of von Willebrand factor in myeloproliferative disease: a relationship with bleeding diathesis.
    Fabris F; Casonato A; Grazia del Ben M; De Marco L; Girolami A
    Br J Haematol; 1986 May; 63(1):75-83. PubMed ID: 3085704
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.